I didn't take it as directed at me at all, you and I are both on exactly the same page.
I was just trying to ease the mind of a certain poster who seems to have violated Rule #1 of investing in pre-rev biotechs, which as we all know is "Don't invest more than you can afford to lose".
Violating Rule #1 can be bad for a person's blood pressure, as we can see by their posts.
So we're set back a few months on covid. Not the end of the world. We're still a tiny biotech that just had better covid results than all the big boys and their unlimited resources and connections. Not too shabby when you step back and look at the big picture. Seems like our little molecule has just proven that it can do even more than fight cancer and HIV, and if the FDA is as legit as NP seems to think (not so sure I agree, but I'll play along) we should be looking at at least an EUA for covid by summer.
Might be some spectular risk/reward buying opportunities if the SP keeps fading.
I was just trying to ease the mind of a certain poster who seems to have violated Rule #1 of investing in pre-rev biotechs, which as we all know is "Don't invest more than you can afford to lose".
Violating Rule #1 can be bad for a person's blood pressure, as we can see by their posts.
So we're set back a few months on covid. Not the end of the world. We're still a tiny biotech that just had better covid results than all the big boys and their unlimited resources and connections. Not too shabby when you step back and look at the big picture. Seems like our little molecule has just proven that it can do even more than fight cancer and HIV, and if the FDA is as legit as NP seems to think (not so sure I agree, but I'll play along) we should be looking at at least an EUA for covid by summer.
Might be some spectular risk/reward buying opportunities if the SP keeps fading.
2
